Sphera Funds Management LTD Boosted Biomarin Pharmaceutical (BMRN) Holding by $930,000; Stock Price Declined; Suffolk Capital Management Has Lowered Carrol’s Restaurant Group (TAST) Holding by $495,730; Valuation Declined

February 13, 2018 - By Adrian Mccoy

Suffolk Capital Management Llc decreased its stake in Carrol’s Restaurant Group Inc. (TAST) by 49.05% based on its latest 2017Q3 regulatory filing with the SEC. Suffolk Capital Management Llc sold 49,573 shares as the company’s stock declined 24.32% while stock markets rallied. The institutional investor held 51,489 shares of the consumer services company at the end of 2017Q3, valued at $561,000, down from 101,062 at the end of the previous reported quarter. Suffolk Capital Management Llc who had been investing in Carrol’s Restaurant Group Inc. for a number of months, seems to be less bullish one the $455.32 million market cap company. The stock increased 1.98% or $0.25 during the last trading session, reaching $12.85. About 275,034 shares traded or 11.23% up from the average. Carrols Restaurant Group, Inc. (NASDAQ:TAST) has risen 0.56% since February 13, 2017 and is uptrending. It has underperformed by 16.14% the S&P500.

Sphera Funds Management Ltd increased its stake in Biomarin Pharmaceutical Inc (BMRN) by 13.33% based on its latest 2017Q3 regulatory filing with the SEC. Sphera Funds Management Ltd bought 10,000 shares as the company’s stock declined 0.71% while stock markets rallied. The institutional investor held 85,000 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $7.91M, up from 75,000 at the end of the previous reported quarter. Sphera Funds Management Ltd who had been investing in Biomarin Pharmaceutical Inc for a number of months, seems to be bullish on the $14.63B market cap company. The stock increased 3.67% or $2.95 during the last trading session, reaching $83.28. About 1.56M shares traded or 22.57% up from the average. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has risen 5.29% since February 13, 2017 and is uptrending. It has underperformed by 11.41% the S&P500.

Among 27 analysts covering BioMarin Pharmaceutical (NASDAQ:BMRN), 21 have Buy rating, 0 Sell and 6 Hold. Therefore 78% are positive. BioMarin Pharmaceutical had 78 analyst reports since August 5, 2015 according to SRatingsIntel. The firm has “Buy” rating by Leerink Swann given on Tuesday, July 18. The firm has “Buy” rating by Deutsche Bank given on Thursday, November 3. Wedbush maintained it with “Neutral” rating and $131 target in Tuesday, September 1 report. On Wednesday, August 5 the stock rating was maintained by William Blair with “Buy”. Credit Suisse maintained the stock with “Outperform” rating in Tuesday, March 22 report. The company was maintained on Wednesday, November 15 by Wedbush. The firm has “Outperform” rating given on Friday, October 27 by BMO Capital Markets. The stock has “Outperform” rating by Credit Suisse on Monday, January 23. The stock of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has “Perform” rating given on Wednesday, November 25 by Oppenheimer. Stifel Nicolaus maintained it with “Buy” rating and $107.0 target in Wednesday, October 18 report.

Sphera Funds Management Ltd, which manages about $700.90M US Long portfolio, decreased its stake in Solaredge Technologies Inc by 69,015 shares to 102,003 shares, valued at $2.91 million in 2017Q3, according to the filing. It also reduced its holding in Nomad Foods Ltd by 101,410 shares in the quarter, leaving it with 166,662 shares, and cut its stake in Immunomedics Inc (NASDAQ:IMMU).

Investors sentiment decreased to 1.13 in 2017 Q3. Its down 0.13, from 1.26 in 2017Q2. It is negative, as 40 investors sold BMRN shares while 116 reduced holdings. 45 funds opened positions while 132 raised stakes. 171.51 million shares or 2.04% more from 168.09 million shares in 2017Q2 were reported. Cornerstone Advsrs holds 0.09% of its portfolio in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) for 1,346 shares. Rice Hall James And has invested 0.04% of its portfolio in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). Asset Mgmt One Commerce Ltd has 0.06% invested in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) for 270,558 shares. Credit Suisse Ag reported 384,418 shares. Sterling Global Strategies Ltd Liability owns 3,000 shares. Eaton Vance Management holds 482,052 shares. Quantbot Techs Limited Partnership invested in 2,833 shares. Wells Fargo And Mn reported 0.02% in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). Bnp Paribas Arbitrage Sa holds 0.01% in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) or 55,521 shares. Howe & Rusling holds 0% or 98 shares. Ameriprise Fin reported 970,764 shares or 0.04% of all its holdings. Polar Capital Llp invested 0.28% in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). Orbimed Limited Liability Corporation has invested 0.66% of its portfolio in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). Point72 Asset Mngmt Ltd Partnership has 769,542 shares. Royal National Bank Of Canada invested in 0% or 34,333 shares.

Since September 15, 2017, it had 0 insider buys, and 9 insider sales for $9.10 million activity. Another trade for 800 shares valued at $71,116 was made by HERON ELAINE J on Thursday, December 14. Shares for $334,495 were sold by Ajer Jeffrey Robert. FUCHS HENRY J had sold 15,000 shares worth $1.34 million on Tuesday, January 2. On Thursday, February 1 Davis George Eric sold $2.72M worth of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) or 30,000 shares. Shares for $342,225 were sold by LAWLIS V BRYAN on Friday, September 15. 10,000 shares were sold by BIENAIME JEAN JACQUES, worth $903,203 on Friday, January 5.

Among 2 analysts covering Carrols Restaurant Group (NASDAQ:TAST), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Carrols Restaurant Group had 3 analyst reports since January 29, 2016 according to SRatingsIntel. Raymond James downgraded the stock to “Outperform” rating in Tuesday, September 26 report. The rating was maintained by Citigroup with “Buy” on Monday, November 20.

Suffolk Capital Management Llc, which manages about $1.92 billion and $757.82M US Long portfolio, upped its stake in Rexford Industrial Realty Inc (NYSE:REXR) by 21,878 shares to 47,157 shares, valued at $1.35 million in 2017Q3, according to the filing. It also increased its holding in United Health Group Inc (NYSE:UNH) by 7,491 shares in the quarter, for a total of 59,187 shares, and has risen its stake in Casella Waste Systems Inc (NASDAQ:CWST).

Since December 14, 2017, it had 0 insider purchases, and 1 sale for $32,000 activity.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>